ARTICLE | Clinical News
Valomaciclovir: Phase IIb started
November 12, 2007 8:00 AM UTC
Epiphany began a Phase IIb trial to compare once-daily valomaciclovir vs. thrice-daily Valtrex valacyclovir from GlaxoSmithKline plc (LSE:GSK; GSK, London, U.K.). Medivir granted Epiphany worldwide ...